Flora Growth Stock In Shambles: Down -37% With 6-Day Losing Streak
Flora Growth (FLGC) stock hit day 6 of a continuous streak of days with losses, with cumulative losses over this period amounting to a -37% return. The company has lost about $3.8 Mil in value over the last 6 days, with its current market capitalization at about $6.4 Mil. The stock remains 71.0% below its value at the end of 2024. This compares with year-to-date returns of 17.2% for the S&P 500.
FLGC provides cannabis cultivation, processing, and supply services to pharmacies, clinics, and cosmetics, along with manufacturing hemp textiles for hospitality, medical, and clothing industries.
A single stock can be risky, but there is a huge value to a broader, diversified approach we take with the Trefis High Quality Portfolio. We go beyond just equities. Is a portfolio of 10% commodities, 10% gold, and 2% crypto in addition to equities and bonds likely to return more during the next 1-3 years, and protect you better if markets crash 20%? We have crunched the numbers.
Comparing FLGC Stock Returns With The S&P 500
The following table summarizes the return for FLGC stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | FLGC | S&P 500 |
|---|---|---|
| 1D | -0.3% | 0.2% |
| 6D (Current Streak) | -37.3% | 2.3% |
| 1M (21D) | -47.5% | 3.4% |
| 3M (63D) | 1746.0% | 8.3% |
| YTD 2025 | -71.0% | 17.2% |
| 2024 | -23.7% | 23.3% |
| 2023 | -70.3% | 24.2% |
| 2022 | -87.2% | -19.4% |
What is the point? Sustained weakness can be more than noise. It often signals shifting sentiment or deeper concerns. A multi-day losing streak may warn of further downside, or present an opportunity to buy if fundamentals are intact.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 52 S&P constituents with 3 days or more of consecutive gains and 80 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 19 | 46 |
| 4D | 27 | 21 |
| 5D | 1 | 9 |
| 6D | 1 | 2 |
| 7D or more | 4 | 2 |
| Total >=3 D | 52 | 80 |
Key Financials for Flora Growth (FLGC)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $76.1 Mil | $59.5 Mil |
| Operating Income | $-10.6 Mil | $-13.0 Mil |
| Net Income | $-57.0 Mil | $-15.9 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ1 | 2025 FQ2 |
|---|---|---|
| Revenues | $11.8 Mil | $14.8 Mil |
| Operating Income | $-2.0 Mil | $-2.3 Mil |
| Net Income | $-0.8 Mil | $-2.4 Mil |
The losing streak FLGC stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.